* The application of the product is exclusively reserved for qualified healthcare professionals.
MEDICAL DEVICE
DUROLANE CE medical device 0086 class III.
Durolane is intended for use in intra-articular injections for the symptomatic treatment of mild to moderate knee or hip osteoarthritis. It is also intended for use in intra-articular injections for the symptomatic treatment of osteoarthritis of synovial joints indicated as mild to moderate and for the reduction of pain following arthroscopic procedures. The product must be injected by a competent physician or in accordance with local legislation. Durolane contains 20 mg/ml of stabilized non-animal hyaluronic acid in buffered saline solution with pH 7. It is a transparent sterile viscoelastic gel provided in a 3 ml glass syringe. The product is for single use only. Hyaluronic acid is identical in all living organisms. It is a natural polysaccharide present in body tissues, with particularly high concentrations in synovial fluid and skin. Durolane consists of biosynthetically produced, purified, and stabilized hyaluronic acid. Durolane is assimilated by the body through the same metabolic pathway as endogenous hyaluronic acid.
Content
Each ml contains:
Stabilized hyaluronic acid 20 mg, sodium chloride physiological solution, pH 7 q.s.
Mode of action
The hyaluronic acid in the body is a natural component of synovial fluid and acts in the joints both as a lubricant for cartilage and ligaments and as a shock absorber. Injections of hyaluronic acid into the joint to restore viscosity and elasticity can reduce pain and improve joint mobility.
